Catalyst Wire Dossier Catalyst Wire Dossier

Micronised purified flavonoid fraction

Diosmin and hesperidin (micronised purified flavonoid fraction)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Micronised purified flavonoid fraction, covering 2017-02-20 to 2017-02-20. Get the full timeline:

Most recent: Clinical Trial Update: EXPLORATORY ASSESSMENT OF THE EFFECTS OF CYCLO 3 ® FORT (Ruscus Extract, Hesperidin Methyl Chalcone, Ascorbic Acid) OR MICRONISED PURIFIED FLAVONOID FRACTION ON VASCULAR PARAMETERS AND BIOMARKERS IN WOMEN SUFFERING FROM CHRONIC VENOUS DISEASE (CEAP C2 OR C3), OVER 8 WEEKS [Phase 2]

See pricing